Cardiology

Just how effective is vitamin D in helping with various conditions? A look at some of the most recent data

A study of the affect prescribing drugs during infancy can have on childhood obesity

As the workload for doctors increases some practices and hospitals are turning to scribes to help with some of the duties. What they should be doing and how much involvement they should have remains a topic of discussion.

A middle-aged man presents with exertional hemoptysis to your clinic. There is no associated chest discomfort with activity. At rest, he has no complaints. His exam is significant for a normal HR and BP and a normal lung exam. His cardiac exam is notable for a gallop. No murmurs are appreciated. A pulmonary evaluation including PFTs and CT PE protocol are negative.

Amgen has released positive top-line results from the first of two Phase III studies of ABP 501, its candidate for the treatment of moderate-to-severe plaque psoriasis that is being developed as a biosimilar to adalimumab.

A closer look at the usage of niacin for patients with vascular disease

This is a 23-year-old female admitted for the first time who provides the history of congenital right chest wall deformity, right hypoplastic breast and absent right pectoralis muscles (1). Preliminary upright PA, lateral and right posterior oblique radiographs were obtained to evaluate the osseous and soft tissues of the thorax prior to cosmetic surgery and repair. No past history was made available.

The new Idiopathic Pulmonary Fibrosis medications that were recently approved will help with treatment for patients but are not a cure for the condition.

Hypersomnia may not receive the amount of attention as other sleep disorders like sleep apnea, but it affects up to 5% of the population and left untreated can significantly diminish a patient's quality of life.

The area of sleep study is only around 30 years old but there are still new advancements that can help improve the daily life of a patient.

As part of the annual meeting of the American College of Chest Physicians new information was rolled out on the "Live Well" Campaign aimed at helping patients with COPD.

AstraZeneca today announced that the US Food and Drug Administration has approved once-daily Xigduo XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of adults with type 2 diabetes mellitus.

Family practice has a reputation for being a low-tech, hands-on specialty. But speaking in a keynote address at the American Academy of Family Physicians Assembly Oct. 26 , Eric Topol, MD told his audience they would do well to use more technologically sophisticated devices.

While the survival rate for lung transplantation may be low compared with other transplant surgeries, advances in technology have helped increase the success rate.

With the approval of two new drugs for the treatment of IPF, patients who otherwise would have only had lung transplantation as a treatment option now have a new way to improve their quality of life.

The 2013 revision of guidelines on managing overweight and obesity in adults suggests that providers and patients set a goal of a sustained weight loss of 3-5% of baseline body weight to obtain improvements in triglycerides, blood glucose, HbA1c, and the risk of developing type 2 diabetes mellitus.

Individuals who engage in physical activity on a regular basis have improved cardiovascular fitness, improved insulin sensitivity, and improved glucose tolerance.

Patients who are overweight or obese have several medication options as an adjunct to lifestyle modification for weight loss.

App will help patients with diabetes log their hypoglycemic events and achieve better control of these events by becoming more aware of preceding signs and symptoms.

Provocative research raises the question of whether we should we look at Alzheimer's disease as "type 3 diabetes."

Presentation at CMHC 2014 provides updates on emerging classes of diabetes treatment, including preliminary data from current clinical trials.

Recent studies of targeted anti-inflammatory therapy show promise for helping patients with high blood pressure and elevated cholesterol levels.

Advances in treatment could provide much needed help for patients with obesity, diabetes, and hypertension

Silent coronary artery disease is often diagnosed too late to prevent a cardiac event. But in a case history involving twin brothers, a team from Liverpool Heart and Chest Hospital, Liverpool, UK shows that investigative imaging of an otherwise healthy man paid off.

Heart patients who have bouts of hypotension while hospitalized for acute decompensated heart failure (ADHF) have an increased risk of an adverse outcome within 30 days, a multi-institutional study found. Priyesh Patel, MD, and colleagues, writing in Circulation reported on their analysis of results of the ASCEND-HF study.

Stress cardiomyopathy is a unique cardiac syndrome in which transient left ventricular (LV) systolic dysfunction mimics acute myocardial infarction (AMI). It is usually brought on by acute emotional or physical stress (or both) and has 3 distinctive features: acute LV wall dysfunction, absence of significant obstructive coronary artery disease, and rapid improvement of LV systolic function within days or weeks.

A collaborative effort from researchers at the University of Pennsylvania and University of Florida has yielded plant leaves as a viable treatment for pulmonary hypertension.

Prompted by almost-epidemic rates of diabetes in the United States and globally, the American Diabetes Association recently convened a consensus panel to examine diabetic kidney disease, one of the most frequent complications associated with diabetes.

Type 2 diabetes occurs at roughly the same prevalence in men and women. Despite the similar prevalence in the sexes, women who develop diabetes feel the effect of its complications disproportionately.

Analysis of a dozen phase III trials indicates that patients with atrial fibrillation face significantly less risk of major, fatal, and intracranial bleeding if they take target-specific oral anticoagulants rather than vitamin K antagonists.